TuHURA Biosciences, Inc.
HURA
$3.48
$0.5719.59%
| Weiss Ratings | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.06% | |||
| 30-Day Total Return | 9.43% | |||
| 60-Day Total Return | -22.49% | |||
| 90-Day Total Return | 15.23% | |||
| Year to Date Total Return | -15.33% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -63.30% | |||
| 52-Week Low % Change | 61.67% | |||
| Price | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $7.93 | |||
| 52-Week Low Price | $1.80 | |||
| 52-Week Low Price (Date) | Mar 10, 2025 | |||
| 52-Week High Price (Date) | Oct 18, 2024 | |||
| Valuation | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 123.16M | |||
| Enterprise Value | 110.98M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.09 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -80.17 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $3.48 | |||
| Enterprise Value/EBITDA (TTM) | -30.02 | |||
| Enterprise Value/EBIT | -29.75 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 76.37M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 813 875 6600 | |||
| Address | 10500 University Center Drive Tampa, FL 33612 | |||
| Website | tuhurabio.com | |||
| Country | United States | |||
| Year Founded | 1993 | |||
| Profitability | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -22.86% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 19.60M | |||
| Cash Per Share (Q) | $0.26 | |||
| Total Current Assets (Q) | 26.72M | |||
| Total Preferred Equity (Q) | 0.01 | |||
| Total Equity (Q) | -2.77M | |||
| Current Ratio (Q) | 4.922 | |||
| Book Value Per Share (Q) | -$0.04 | |||
| Total Assets (Q) | 27.11M | |||
| Total Current Liabilities (Q) | 5.43M | |||
| Total Debt (Q) | 24.61M | |||
| Total Liabilities (Q) | 29.88M | |||
| Total Common Equity (Q) | -2.78M | |||
| Cash Flow | HURA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
